Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Revenue	285.97	243.6	214.27	202.13	180.86	156.8	137.79	122.54	112.21	108.63	79.86	83.4	67.05	71.47	48.35	61.88	99.14	26.97	32.19	18.75
Revenue Growth (YoY)	58.12%	55.36%	55.51%	64.95%	61.17%	44.34%	72.54%	46.93%	67.37%	51.99%	65.18%	34.76%	-32.37%	164.99%	50.19%	230.14%	719.64%	250.10%	-	-
Cost of Revenue	133.59	111.64	96.37	90.98	83.56	71.02	61.66	66.09	49.42	42.34	31.38	26.52	26.4	21.69	15.32	14.23	11.56	8.7	12.47	4.7
Gross Profit	152.38	131.96	117.89	111.15	97.29	85.78	76.13	56.45	62.8	66.3	48.47	56.87	40.65	49.79	33.02	47.65	87.58	18.27	19.72	14.04
Selling, General & Admin	65.36	63.87	61.15	56.78	49.1	46.86	43.53	40.54	46.4	42.4	38.68	36.74	34.47	29.18	29.05	27.22	24.68	23.84	22.22	22.74
Research & Development	32.79	40.9	27.48	34.61	24.17	18.75	19.33	35.22	26.06	24.02	26.33	20.05	17.11	23.77	15.17	14.39	16.49	13.8	20.82	27.43
Operating Expenses	98.15	104.77	88.63	91.38	73.27	65.62	62.86	75.75	72.46	66.41	65.02	56.79	51.57	52.94	44.22	41.61	41.16	37.64	43.04	50.17
Operating Income	54.24	27.19	29.27	19.77	24.02	20.16	13.27	-19.3	-9.66	-0.12	-16.54	0.08	-10.93	-3.15	-11.2	6.05	46.41	-19.37	-23.32	-36.13
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.02
Interest & Investment Income	4.99	-	-	-	3.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non Operating Income (Expenses)	-0.17	3.95	3.41	3.5	-0.01	2.72	2.29	2.32	2.46	2.42	2.27	2.37	2.43	1.92	1.83	0.79	0.32	0.1	0.03	0.1
Pretax Income	59.06	31.15	32.68	23.27	27.16	22.88	15.57	-16.98	-7.2	2.3	-14.28	2.45	-8.5	-1.24	-9.36	6.84	46.74	-19.27	-23.29	-36.05
Income Tax Expense	11.71	5.71	10.09	9.07	8.72	5.05	7.03	-8.09	5.49	6.21	3.43	-22.79	5.36	-16.21	2.91	2.38	-177.36	0.72	1.93	0.28
Net Income	47.35	25.43	22.59	14.2	18.44	17.83	8.54	-8.89	-12.69	-3.91	-17.7	25.24	-13.86	14.97	-12.27	4.46	224.09	-19.98	-25.21	-36.33
Net Income to Common	47.35	25.43	22.59	14.2	18.44	17.83	8.54	-8.89	-12.69	-3.91	-17.7	25.24	-13.86	14.97	-12.27	4.46	224.09	-19.98	-25.21	-36.33
Net Income Growth (YoY)	156.82%	42.62%	164.57%	-	-	-	-	-	-	-	-	465.73%	-	-	-	-	-	-	-	-
Shares Outstanding (Basic)	78	78	77	76	75	73	73	72	72	71	71	70	70	70	70	70	69	69	69	69
Shares Outstanding (Diluted)	85	83	82	82	80	78	76	72	72	71	71	73	70	72	70	71	71	69	69	69
Shares Change (YoY)	6.10%	7.00%	8.23%	12.79%	11.58%	9.77%	7.80%	-0.47%	2.20%	-0.88%	1.26%	1.81%	-0.52%	3.38%	0.89%	3.48%	2.75%	1.31%	1.27%	1.33%
EPS (Basic)	0.61	0.33	0.30	0.19	0.25	0.24	0.12	-0.12	-0.18	-0.06	-0.25	0.36	-0.20	0.21	-0.18	0.06	3.23	-0.29	-0.36	-0.53
EPS (Diluted)	0.56	0.30	0.27	0.18	0.23	0.23	0.11	-0.12	-0.18	-0.06	-0.25	0.35	-0.20	0.21	-0.18	0.05	3.18	-0.29	-0.36	-0.53
EPS Growth (YoY)	143.48%	30.43%	145.46%	-	-	-	-	-	-	-	-	549.01%	-	-	-	-	-	-	-	-

Additional Metrics

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Free Cash Flow	47.37	46.53	50.04	53.26	33.01	27.93	22.23	18.58	-2.24	5.17	3.9	4.27	16.97	-3.78	-4.29	-11.54	62.03	-7.94	-36.85	-19.14
Free Cash Flow Per Share	0.56	0.56	0.61	0.65	0.41	0.36	0.29	0.26	-0.03	0.07	0.06	0.06	0.24	-0.05	-0.06	-0.16	0.88	-0.12	-0.53	-0.28
Gross Margin	53.29%	54.17%	55.02%	54.99%	53.80%	54.71%	55.25%	46.07%	55.96%	61.03%	60.70%	68.20%	60.63%	69.66%	68.30%	77.00%	88.34%	67.74%	61.25%	74.92%
Operating Margin	18.97%	11.16%	13.66%	9.78%	13.28%	12.86%	9.63%	-15.75%	-8.61%	-0.11%	-20.71%	0.10%	-16.30%	-4.41%	-23.16%	9.77%	46.82%	-71.81%	-72.44%	-192.75%
Profit Margin	16.56%	10.44%	10.54%	7.03%	10.19%	11.37%	6.20%	-7.25%	-11.31%	-3.60%	-22.17%	30.26%	-20.66%	20.95%	-25.38%	7.21%	226.05%	-74.08%	-78.32%	-193.83%
Free Cash Flow Margin	16.56%	19.10%	23.35%	26.35%	18.25%	17.81%	16.13%	15.16%	-1.99%	4.76%	4.89%	5.12%	25.31%	-5.29%	-8.88%	-18.65%	62.57%	-29.43%	-114.47%	-102.08%
EBITDA	54.73	27.67	29.74	20.24	24.41	20.52	13.62	-18.9	-9.26	0.31	-16.08	0.62	-10.32	-2.55	-10.6	6.65	46.91	-18.72	-22.66	-35.46
EBITDA Margin	19.14%	11.36%	13.88%	10.01%	13.49%	13.09%	9.88%	-15.42%	-8.25%	0.29%	-20.13%	0.74%	-15.40%	-3.57%	-21.93%	10.74%	47.32%	-69.39%	-70.41%	-189.19%
D&A For EBITDA	0.49	0.47	0.47	0.47	0.38	0.36	0.35	0.4	0.4	0.43	0.47	0.54	0.6	0.6	0.6	0.6	0.49	0.65	0.66	0.67
EBIT	54.24	27.19	29.27	19.77	24.02	20.16	13.27	-19.3	-9.66	-0.12	-16.54	0.08	-10.93	-3.15	-11.2	6.05	46.41	-19.37	-23.32	-36.13
EBIT Margin	18.97%	11.16%	13.66%	9.78%	13.28%	12.86%	9.63%	-15.75%	-8.61%	-0.11%	-20.71%	0.10%	-16.30%	-4.41%	-23.16%	9.77%	46.82%	-71.81%	-72.44%	-192.75%
Effective Tax Rate	19.83%	18.34%	30.87%	38.98%	32.12%	22.05%	45.14%	-	-	269.62%	-	-	-	-	-	34.79%	-	-	-	-
Revenue as Reported	285.97	243.6	214.27	202.13	180.86	156.8	137.79	122.54	112.21	108.63	79.86	83.4	67.05	71.47	48.35	61.88	99.14	26.97	32.19	18.75

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error